TY - STD TI - Global Strategy for Asthma Management and Prevention. [http://www.ginasthma.org] UR - http://www.ginasthma.org ID - ref1 ER - TY - STD TI - Ventolin Evohaler Summary of Product Characteristics. [http://www.medicines.org.uk/emc/medicine/97/SPC] UR - http://www.medicines.org.uk/emc/medicine/97/SPC ID - ref2 ER - TY - STD TI - Serevent Accuhaler Summary of Product Characteristics. [http://www.medicines.org.uk/emc/medicine/91] UR - http://www.medicines.org.uk/emc/medicine/91 ID - ref3 ER - TY - STD TI - Formoterol Easyhaler Summary of Product Characteristics. [http://www.medicines.org.uk/emc/medicine/19503/SPC] UR - http://www.medicines.org.uk/emc/medicine/19503/SPC ID - ref4 ER - TY - STD TI - Relvar Ellipta Summary of Product Characteristics. [http://www.medicines.org.uk/emc/medicine/28496/SPC/] UR - http://www.medicines.org.uk/emc/medicine/28496/SPC/ ID - ref5 ER - TY - JOUR AU - Cazzola, M. AU - Matera, M. G. PY - 2008 DA - 2008// TI - Novel long-acting bronchodilators for COPD and asthma JO - Br J Pharmacol VL - 155 UR - https://doi.org/10.1038/bjp.2008.284 DO - 10.1038/bjp.2008.284 ID - Cazzola2008 ER - TY - JOUR AU - Aparici, M. AU - Gómez-Angelats, M. AU - Vilella, D. AU - Otal, R. AU - Carcasona, C. AU - Viñals, M. AU - Ramos, I. AU - Gavaldá, A. AU - De Alba, J. AU - Gras, J. AU - Cortijo, J. AU - Morcillo, E. AU - Puig, C. AU - Ryder, H. AU - Beleta, J. AU - Miralpeix, M. PY - 2012 DA - 2012// TI - Pharmacological characterization of abediterol, a novel inhaled β(2)-adrenoceptor agonist with long duration of action and a favorable safety profile in preclinical models JO - J Pharmacol Exp Ther VL - 342 UR - https://doi.org/10.1124/jpet.112.193284 DO - 10.1124/jpet.112.193284 ID - Aparici2012 ER - TY - JOUR AU - Aparici, M. AU - Gómez-Angelats, M. AU - Vilella, D. AU - Cortijo, J. AU - Morcillo, E. J. AU - Carcasona, C. AU - Gavaldà, A. AU - Beleta, J. AU - Puig, C. AU - Ryder, H. AU - Miralpeix, M. PY - 2010 DA - 2010// TI - The in vitro pharmacological profile of LAS100977 – a potent, selective and long-acting beta-2 receptor agonist [abstract A5675] JO - Am J Respir Crit Care Med VL - 181 ID - Aparici2010 ER - TY - CHAP AU - Miralpeix, M. AU - Aparici, M. AU - Carcasona, C. AU - Ramos, I. AU - Puig, C. AU - Vilella, D. AU - Gavalda, A. PY - 2014 DA - 2014// BT - Abediterol (LAS100977) is A Potent and Selective β2-Agonist with Sustained Duration of Action and Favourable Selectivity in Vitro [poster] PB - Presented at the American Thoracic Society Annual Congress CY - San Diego, CA, USA ID - Miralpeix2014 ER - TY - CHAP AU - De Alba, J. AU - Otal, R. AU - Fernández-Blanco, J. A. AU - Aparici, M. AU - Puig, C. AU - Gavaldà, A. AU - Miralpeix, M. PY - 2014 DA - 2014// BT - Abediterol (LAS100977) Demonstrates a Higher Potency and a Longer Duration of Action in Comparison with Other Long-Acting Β2-Adrenoceptor Agonists in a Guinea Pig Bronchoconstriction Model [poster] PB - Presented at the American Thoracic Society Annual Congress CY - San Diego, CA, USA ID - De Alba2014 ER - TY - JOUR AU - Beier, J. AU - Fuhr, R. AU - Massana, È. AU - Jiménez, E. AU - Seoane, B. AU - de Miquel, G. AU - Ruiz, S. PY - 2010 DA - 2010// TI - Efficacy and safety of single inhaled doses of LAS100977, a novel long acting β2-agonist, in patients with persistent asthma [abstract A5414] JO - Am J Respir Crit Care Med VL - 181 ID - Beier2010 ER - TY - JOUR AU - Miralpeix, M. AU - Gomez-Angelats, M. AU - Aparici, M. AU - Vinals, M. AU - Beleta, J. AU - Gavalda, A. PY - 2010 DA - 2010// TI - LAS100977, a novel beta-2 receptor agonist, with a longer duration of action and more favourable safety margin than salmeterol in anesthetised dogs [abstract A5676] JO - Am J Respir Crit Care Med VL - 181 ID - Miralpeix2010 ER - TY - JOUR AU - Timmer, W. AU - Massana, E. AU - Jiménez, E. AU - Seoane, B. AU - de Miquel, G. AU - Ruiz, S. PY - 2010 DA - 2010// TI - Single doses of LAS100977, a novel long acting β2-agonist, show high activity and long duration in healthy subjects [abstract A5663] JO - Am J Respir Crit Care Med VL - 181 ID - Timmer2010 ER - TY - CHAP AU - Beier, J. AU - Fuhr, R. AU - Massana, E. AU - Jiménez, E. AU - Seoane, B. AU - de Miquel, G. AU - Ruiz, S. PY - 2010 DA - 2010// BT - Efficacy and Safety of Single Inhaled Doses of LAS100977, A Novel Long Acting β2-Agonist, in Patients with Persistent Asthma [poster] PB - Presented at the American Thoracic Society International Conference CY - New Orleans, Louisiana, USA ID - Beier2010 ER - TY - CHAP AU - Beier, J. AU - Pujol, H. AU - Seoane, B. AU - Jiménez, E. AU - Astbury, C. AU - Massana, E. AU - Ruiz, S. AU - de Miquel, G. PY - 2013 DA - 2013// BT - Efficacy and Safety of Abediterol (LAS100977) in Patients with COPD: Phase III, Randomized, Crossover Study [poster] PB - Presented at the European Respiratory Society Annual Congress CY - Barcelona, Spain ID - Beier2013 ER - TY - JOUR AU - Chowdhury, B. AU - Seymour, S. M. AU - Michele, T. M. AU - Durmowicz, A. G. AU - Liu, D. AU - Rosebraugh, C. J. PY - 2011 DA - 2011// TI - The risks and benefits of indacaterol–the FDA’s review JO - N Engl J Med VL - 365 UR - https://doi.org/10.1056/NEJMp1109621 DO - 10.1056/NEJMp1109621 ID - Chowdhury2011 ER - TY - JOUR AU - Whale, C. I. AU - Sovani, M. P. AU - Mortimer, K. J. AU - Harrison, T. W. AU - Tattersfield, A. E. PY - 2008 DA - 2008// TI - Systemic and bronchodilator effects of inhaled rac-formoterol in subjects with chronic obstructive pulmonary disease: a dose–response study JO - Br J Clin Pharmacol VL - 65 UR - https://doi.org/10.1111/j.1365-2125.2007.03081.x DO - 10.1111/j.1365-2125.2007.03081.x ID - Whale2008 ER - TY - JOUR AU - Beeh, K. M. AU - Beier, J. PY - 2010 DA - 2010// TI - The short, the long and the “ultra-long”: why duration of bronchodilator action matters in chronic obstructive pulmonary disease JO - Adv Ther VL - 27 UR - https://doi.org/10.1007/s12325-010-0017-6 DO - 10.1007/s12325-010-0017-6 ID - Beeh2010 ER - TY - JOUR AU - Pellegrino, R. AU - Viegi, G. AU - Brusasco, V. AU - Crapo, R. O. AU - Burgos, F. AU - Casaburi, R. AU - Coates, A. AU - van der Grinten, C. P. AU - Gustafsson, P. AU - Hankinson, J. AU - Jensen, R. AU - Johnson, D. C. AU - MacIntyre, N. AU - McKay, R. AU - Miller, M. R. AU - Navajas, D. AU - Pedersen, O. F. AU - Wanger, J. PY - 2005 DA - 2005// TI - Interpretative strategies for lung function tests JO - Eur Respir J VL - 26 UR - https://doi.org/10.1183/09031936.05.00035205 DO - 10.1183/09031936.05.00035205 ID - Pellegrino2005 ER - TY - JOUR AU - Quanjer, P. H. AU - Tammeling, G. J. AU - Cotes, J. E. AU - Pedersen, O. F. AU - Peslin, R. AU - Yernault, J. C. PY - 1993 DA - 1993// TI - Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society JO - Eur Respir J Suppl VL - 16 UR - https://doi.org/10.1183/09041950.005s1693 DO - 10.1183/09041950.005s1693 ID - Quanjer1993 ER - TY - JOUR AU - Crompton, G. PY - 2006 DA - 2006// TI - A brief history of inhaled asthma therapy over the last fifty years JO - Prim Care Respir J VL - 15 UR - https://doi.org/10.1016/j.pcrj.2006.09.002 DO - 10.1016/j.pcrj.2006.09.002 ID - Crompton2006 ER - TY - JOUR AU - Cazzola, M. AU - Page, C. P. AU - Calzetta, L. AU - Matera, M. G. PY - 2012 DA - 2012// TI - Pharmacology and therapeutics of bronchodilators JO - Pharmacol Rev VL - 64 UR - https://doi.org/10.1124/pr.111.004580 DO - 10.1124/pr.111.004580 ID - Cazzola2012 ER - TY - JOUR AU - Palmqvist, M. AU - Persson, G. AU - Lazer, L. AU - Rosenborg, J. AU - Larsson, P. AU - Lötvall, J. PY - 1997 DA - 1997// TI - Inhaled dry-powder formoterol and salmeterol in asthmatic patients: onset of action, duration of effect and potency JO - Eur Respir J VL - 10 UR - https://doi.org/10.1183/09031936.97.10112489 DO - 10.1183/09031936.97.10112489 ID - Palmqvist1997 ER - TY - JOUR AU - Bodzenta-Lukaszyk, A. AU - Dymek, A. AU - McAulay, K. AU - Mansikka, H. PY - 2011 DA - 2011// TI - Fluticasone/formoterol combination therapy is as effective as fluticasone/salmeterol in the treatment of asthma, but has a more rapid onset of action: an open-label, randomized study JO - BMC Pulm Med VL - 11 UR - https://doi.org/10.1186/1471-2466-11-28 DO - 10.1186/1471-2466-11-28 ID - Bodzenta-Lukaszyk2011 ER - TY - JOUR AU - Beier, J. AU - Pujol, H. AU - Seoane, B. AU - Jiménez, E. AU - Astbury, C. AU - Massana, E. AU - Ruiz, S. AU - de Miquel, G. PY - 2013 DA - 2013// TI - Efficacy and safety of abediterol (LAS100977) in patients with COPD: Phase II, randomized, crossover study [abstract 83] JO - Eur Respir J VL - 42 ID - Beier2013 ER - TY - JOUR AU - Chapman, K. R. AU - Walker, L. AU - Cluley, S. AU - Fabbri, L. PY - 2000 DA - 2000// TI - Improving patient compliance with asthma therapy JO - Respir Med VL - 94 UR - https://doi.org/10.1053/rmed.1999.0667 DO - 10.1053/rmed.1999.0667 ID - Chapman2000 ER - TY - JOUR AU - Makela, M. J. AU - Backer, V. AU - Hedegaard, M. AU - Larsson, K. PY - 2013 DA - 2013// TI - Adherence to inhaled therapies, health outcomes and costs in patients with asthma and COPD JO - Respir Med VL - 107 UR - https://doi.org/10.1016/j.rmed.2013.04.005 DO - 10.1016/j.rmed.2013.04.005 ID - Makela2013 ER - TY - JOUR AU - Wells, K. E. AU - Peterson, E. L. AU - Ahmedani, B. K. AU - Williams, L. K. PY - 2013 DA - 2013// TI - Real-world effects of once vs greater daily inhaled corticosteroid dosing on medication adherence JO - Ann Allergy Asthma Immunol VL - 111 UR - https://doi.org/10.1016/j.anai.2013.06.008 DO - 10.1016/j.anai.2013.06.008 ID - Wells2013 ER - TY - STD TI - The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2466/14/176/prepub UR - http://www.biomedcentral.com/1471-2466/14/176/prepub ID - ref29 ER -